Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Acta Otolaryngol. 2013 Mar;133(3):281-90. doi: 10.3109/00016489.2012.732708. Epub 2012 Nov 8.

Genetic and protein markers related to laryngeal epithelial precursor lesions and their neoplastic progression.

Author information

  • 1Department of Otorhinolaryngology and Instituto Universitario de Oncología del Principado de Asturias, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.

Abstract

CONCLUSION:

Various biomarkers might ultimately prove to have prognostic value and could be clinically relevant. It is mandatory confirm the prognostic power of these markers in large, well-designed, and prospective studies.

OBJECTIVE:

The aim of this study was to investigate the possible role of specific genes and proteins in laryngeal tumorigenesis.

METHODS:

Genetic analysis by multiple ligation-dependent probe amplification and analysis of protein expression by immunohistochemistry were carried out in a series of 50 tissue samples.

RESULTS:

In the smoker normal mucosa group TP53 loss was predominant, whereas in the epithelial precursor lesions (EPLs) CDKN2A loss and BCL2L1 gain were most frequent. EPL with progression presented CTNNB1 loss. Positivity at cytoplasm for β-catenin, cyclin D1 and p53 was detected in all EPL cases with progression to invasive carcinoma. Multivariate analysis showed that expression of β-catenin and loss of CTTNB1 were associated with laryngeal cancer risk.

PMID:
23137024
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk